Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $122.43M.
ENTERPRISE VALUE (EV)
$122.43M
LifeMD, Inc.
Market Cap
$159.22M
Enterprise Value (EV)
$122.43M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| LifeMD, Inc. (LFMDP) | $159.22M | $122.43M |
| PepGen Inc. (PEPG)vs › | $159.44M | $152.76M |
| Minerva Neurosciences, Inc. (NERV)vs › | $161.07M | $136.41M |
| Coherus Oncology, Inc. (CHRS)vs › | $161.45M | $116.24M |
| Inogen, Inc. (INGN)vs › | $156.90M | $85.41M |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $156.62M | $173.99M |
| Quanterix Corporation (QTRX)vs › | $162.75M | $151.97M |
| Nkarta, Inc. (NKTX)vs › | $164.91M | $213.49M |
| Neuronetics, Inc. (STIM)vs › | $153.44M | $220.77M |
| OptimizeRx Corp. (OPRX)vs › | $165.23M | $160.61M |
Market Cap
$159.22M
Total Debt
$0.00
Cash
$36.79M
Enterprise Value
$122.43M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
